Volver a Agenda
Session 7: The EU Investigational Medicinal Product Dossier
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- Scope
- Required Information
- Structure
¿Tiene una cuenta?